GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aeterna Zentaris, Inc. (AEZS) [hlAlert]

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology. The product pipeline of the Company encompasses compounds at all stages of development, from drug discovery
through marketed products. The Company’s principal product candidates include cetrorelix for benign prostatic hyperplasia (BPH) and AEZS-108 for endometrial and ovarian cancers. In January 2007, the Company completed the spin-off of Atrium Biotechnologies Inc., known as Atrium Innovations (Atrium). On November 30, 2007, the Company completed the sale of its Utah-based subsidiary, Echelon Biosciences Inc. (Echelon), to Frontier Scientific Inc.
( Total: 12 Current Stock Recommendations )
Aeterna Zentaris, Inc.   (12)
Buy 100%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Sinovac Biotech, ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
8/15/2007  
Buy
  
10/3/2007  
Buy
  
6/3/2008  
Buy
  
11/6/2008  
Buy
  
11/29/2010  
Buy
  
4/27/2011  
Buy
  
5/31/2011  
Buy
  
6/7/2011  
Buy
  
9/20/2012  
Buy
  
1/3/2013  
Buy
  
11/23/2015  
Buy
  
12/2/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy